PentaBase receives funding from anonymous investor

11/20/2008 | GenomeWeb Daily News (free registration)

PentaBase this week announced that it received $339,000 from an unnamed investor. The Danish company, which is developing diagnostic tools for influenza and bird flu, said it will use the funds to boost the sales of its platform technologies, services and diagnostic tests for infectious diseases.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC